/
DCF Valuation
Base-case fair value
$2.04
Intrinsic $2.72 · 25% MOS
Current price: $2.34
Base-case summary
Our base-case DCF for Organogenesis Holdings Inc. (ORGO) projects 10 years of free cash flow growth at 2.0% for years 1–5 and 1.0% for years 6–10, anchored to a default 8% growth assumption, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from $17M in trailing free cash flow, this produces an intrinsic value of $2.72 per share. A 25% safety margin gives a fair value of $2.04, suggesting the stock is currently 13% overvalued against the $2.34 market price.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
$17M
Cash & equivalents
$91M
Total debt
$39M
Shares outstanding
128M